42 results about "Menopausal disorders" patented technology

In one aspect, the present invention is directed to methods for treating fatigue, neurobehavioral slowing and other cognitive disorders and defects due to cancers and treatments associated with cancers, and similar conditions. In a further aspect, the present invention is directed to methods for treating disorders related to menopause, including executive function defects. The methods involve the administration of a composition comprising D-threo methylphenidate that is substantially free of L-threo methylphenidate and of erythro forms of methylphenidate.

Methods, formulations, and devices for providing transdermal or transmucosal delivery of active agents to subjects in need thereof. The formulations and methods treat symptoms of hormonal disorders including hypogonadism, female sexual desire disorder, female menopausal disorder, and adrenal insufficiency.

It is to provide a pharmaceutical composition which is different from an existing therapeutic agent of an adult disease, of a biochemical reaction-inhibiting type, and which action mechanism is to improve the basal metabolism, wherein the composition has no side effects, and does not generate drug resistance against adult disease; and a method for preventing / treating an adult disease by using the same. It is to provide a composition for preventing / ameliorating an adult disease such as metabolic syndrome, diabetes, hyperlipidemia, hypertension, impaired liver function, renal failure, adiposity, erectile dysfunction, menopausal disorder, shoulder discomfort, and low back pain, comprising 5-aminolevulinic acid (ALA), its derivative, or salt thereof, preferably comprising ALA, its derivative, or salt thereof, and an iron compound such as sodium ferrous citrate, iron sodium citrate and iron ammonium citrate; a food or food material for preventing / ameliorating an adult disease comprising the composition; and a method for using the composition for preparing an agent for preventing / ameliorating an adult disease.

A pharmaceutical composition which is different from an existing therapeutic agent of an adult disease, of a biochemical reaction-inhibiting type, and which action mechanism is to improve the basal metabolism, wherein the composition has no side effects, and does not generate drug resistance against adult disease; and a method for preventing / treating an adult disease by using the same. A composition for preventing / ameliorating an adult disease such as metabolic syndrome, diabetes, hyperlipidemia, hypertension, impaired liver function, renal failure, adiposity, erectile dysfunction, menopausal disorder, shoulder discomfort, and low back pain, comprising 5-aminolevulinic acid (ALA), its derivative, or salt thereof, preferably comprising ALA, its derivative, or salt thereof, and an iron compound such as sodium ferrous citrate, iron sodium citrate and iron ammonium citrate; a food or food material for preventing / ameliorating an adult disease comprising the composition; and a method for using the composition for preparing an agent for preventing / ameliorating an adult disease.

Soymilk is provided which can prevent or alleviate menopausal disorders, and is highly safe with no risk of side effects even with long-term intake thereof. This soymilk is made from germinated soybeans, and is used for alleviating or preventing the vasomotor disorder-like symptoms and psychoneuropathic disorder-like symptoms associated with menopausal disorders. Furthermore, this soymilk is labeled with a notice specifying that the soymilk is to be used for alleviating or preventing the vasomotor disorder-like symptoms and psychoneuropathic disorder-like symptoms of menopausal disorders.

Disclosed is a method for producing an estrogen-like active intermediate (e.g., secoisolariciresinol) by culturing a lignan (e.g., a lignan derived from Gymnema sylvestre) together with a bacterium Lactobacillus acidophilus. Also disclosed a prophylactic / ameliorating agent for menopausal disorder and a functional beverage / food for preventing / ameliorating menopausal disorder comprising a lignan cultured together with a bacterium Lactobacillus acidophilus as an active ingredient.

The invention discloses a medicine and a granule used for climacteric syndrome. The medicine comprises the following components in parts by weight: 10-30 parts of prepared rehmannia roots, 5-10 parts of radix bupleuri, 1-10 parts of tortoise-shell glue, 10-20 parts of cortex phellodendri chinensis, 10-20 parts of rhizoma anemarrhenae, 1-5 parts of rhizoma cyperi, 10-30 parts of white paeony root, 10-20 parts of herba leonuri, 2-3 parts of cassia twig, 1-10 parts of herba lycopi, 10-30 parts of cornus officinalis, 1-5 parts of red flowers, 25-35 parts of white poria, 5-10 parts of myrrh, 1-5 parts of Chinese angelica, 1-5 parts of teasel root, 1-5 parts of rhizoma corydalis, 10-20 parts of semen cuscutae and 10-30 parts of herba schizonepetae. The medicine disclosed by the invention has the effects of regulating liver and tonifying kidney, and nourishing yin to lessen fire, is mainly used for treating menopausal syndrome (menopausal disorders) which belongs to syndromes of yin deficiency of liver and kidney according to the traditional Chinese medicine differentiation, wherein the syndromes include dryness-heat flushing, dizziness and tinnitus, soreness and weakness of waist and knees or painful heel, insomnia and dreaminess, edginess and irritability.

The present invention relates to a composition for improving female climacteric (menopausal) disorder, comprising a combination of a red clover extract and a hops extract as an active ingredient. More specifically, the present invention relates to a food composition for improving female climacteric diseases or a pharmaceutical composition for preventing or treating female climacteric diseases, and a method for preparing the composition for improving female climacteric diseases, wherein the composition comprises the combination of the red clover extract and the hops extract as an active ingredient.

The invention discloses the application of a composite containing polygonum orientale in preparing medicaments for preventing and treating climacteric diseases and delaying aging. The composite is prepared from extracts of polygonum orientale, panax notoginseng, hawthorn leaves and Rhizoma Chuanxiong. The invention provides a novel medical application of the composite containing polygonum orientale and a new medicine selection for patients.

The present invention relates to hot flash-suppressing agents and menopausal disorder-improving agents and a food and drink and a pharmaceutical preparation for suppressing hot flash, containing α-lactalbumin as an active ingredient.

The invention relates to the medical use of motherwort for menopausal diseases. Specifically, the present invention provides the medical use of motherwortine or its pharmaceutically acceptable salt for preventing or treating climacteric syndrome and diseases related to climacteric syndrome.

The present invention relates to a composition for preventing and treating climacteric symptoms comprising the extract of Sophorae Fructus as an effective ingredient. Precisely, the present invention relates to the extract of Sophorae Fructus having an effect of preventing and treating climacteric symptoms, a composition comprising the extract and a method for preventing and treating climacteric symptoms by administering the composition. The extract of Sophorae Fructus of the present invention has activities of promoting the osteoblast proliferation, inhibiting the secretion of bone-absorptive cytokines, promoting the secretion of growth factors involved in bone-reformation, stimulating the generation of nitric oxide in osteoblasts and inhibiting the osteoclast differentiation. In addition, the extract also reduces the concentration of a bone absorption index and inhibits the decrease of calcium content and bone density. Therefore, the extract of Sophorae Fructus of the present invention can be effectively used for the prevention and the treatment of climacteric symptoms including osteoporosis.

The present invention discloses pharmaceutical / nutritional compositions and methods for alleviating symptoms associated with perimenopausal and / or menopausal disorder or discomfort. The methods include the step of administering, to a subject in need thereof, an effective amount of a composition including at least 2% (w / w) phosphatidic acid, or salts thereof, out of the total effective composition, as a first effective ingredient for alleviating at least one discomfort symptom. Preferably, the composition further includes a suitable amount of at least one bio-available form of magnesium as a second effective ingredient. Preferably, at least one bio-available form is selected from the group consisting of: magnesium oxide, magnesium citrate, magnesium hydroxide, magnesium stearate, and a magnesium salt of the phosphatidic acid. Preferably, the step of administering is performed in a multi-part regimen, and is performed by at least one delivery method selected from the group consisting of: oral delivery and intravenous delivery.

The invention relates to application of a Chinese medicinal preparation, in particular to application of a compound polygonum orientale preparation in preparing medicaments for preventing and treating climacteric diseases and delaying senility, wherein the compound polygonum orientale preparation consists of polygonum orientale and erigeron breviscapus.

The invention discloses a red yeast linseed meal fermented product and its application, and belongs to the technical field of food processing. A monascus flax meal fermented product is prepared according to the following steps: (1) primary detoxification of the flaxseed meal: controlling the moisture content of the flaxseed meal to 170-200 g / kg, and detoxifying by 800W microwave for 8 minutes; (2) ) Flaxseed meal fermentation and further detoxification: activate Monascus slant for 3 to 4 times, insert into the seed medium, cultivate at 30°C for 3 days, then insert 10% of the inoculum into the fermentation medium, and culture at 30°C 5-7d, after the fermentation is completed, the fermentation broth is concentrated. The invention can not only improve the economic added value of flaxseeds, but also generate huge economic and social benefits.

The present invention relates to: a pharmaceutical composition for preventing or treating menopausal disorders, containing a Tetragonia tetragonoides (Pall.) Kuntze extract or a fraction thereof; a method for preventing or treating menopausal disorders, comprising a step of administering the pharmaceutical composition; and a food composition containing the extract or a fraction thereof. The Tetragonia tetragonoides (Pall.) Kuntze extract of the present invention shows effects of alleviating obesity, which is representative of glucose metabolism disorders and lipid metabolism disorders, osteoporosis, which is representative of bone homeostasis disorders, and flushing, which is representative of energy metabolism disorders, and thus the extract can be used in food, a medicine and the like soas to prevent, alleviate or treat menopausal disorders.

Novel mercaptophenyl naphthyl methane compounds, their pharmaceutically acceptable salts and compositions comprised thereof are useful for the prevention or treatment of various medical indications associated with estrogen dependent diseases or syndromes related to osteoporosis, bone loss, bone formation, cardiovascular disorders, neurodegenerative disorders, menopausal disorders, physiological disorders, diabetes disorders, prostatic carcinoma, cancer of breast, cancer of uterus, cancer of the cervix and cancer of the colon, threatened or habitual abortion, obesity, ovarian development or function, post-partum lactation and depression.